Researchers Study Non-Invasive Breast Cancer Monitoring
A new clinical study explores whether active surveillance can replace surgery for certain early-stage breast cancer patients.
Updated on Oct. 30, 2026 in Cancer
Live Poll
Would you trust a doctor’s recommendation to monitor early-stage cancer rather than choosing immediate surgery?
Researchers are investigating if patients with ductal carcinoma in situ, a non-invasive breast cancer, can be safely monitored rather than immediately undergoing surgery. The approach utilizes low-dose hormone therapy and regular imaging to detect potential disease progression.
Why it matters
Medical experts aim to determine if some early-stage breast cancers are currently being overtreated with invasive procedures. This study seeks to prevent the development of invasive cancer while sparing patients from unnecessary surgery.
Ductal carcinoma in situ accounts for approximately 35% of all new breast cancer cases in the United States annually. Patients in the study receive mammograms or other imaging every six months to monitor for potential changes.
The players
Montefiore Einstein Comprehensive Cancer Center
This is a medical institution that serves as the site for the current active surveillance study regarding ductal carcinoma in situ.
Julia Stalder
A 46-year-old patient who was diagnosed with ductal carcinoma in situ in April 2024.
The details
At the Montefiore Einstein Comprehensive Cancer Center, participants receive low-dose hormone therapy alongside regular screening. Surgery is only performed if follow-up imaging indicates that the disease is progressing.
Timeline
Julia Stalder was diagnosed with ductal carcinoma in situ in April 2024.
Patients undergo mammograms or other imaging for surveillance every 6 months.
The Big Picture
The active surveillance study at Montefiore Einstein Comprehensive Cancer Center challenges the long-standing reliance on immediate surgical intervention for early-stage breast cancer. This research reflects a broader shift toward de-escalating treatment to avoid potential overtreatment.
Patients may eventually see a shift toward less invasive monitoring routines rather than automatic surgery for early-stage diagnoses. This could reduce surgical risks and recovery times for those diagnosed with non-invasive breast cancer.
The takeaway
Patients diagnosed with early, non-invasive breast cancer may have new, less aggressive options that rely on careful monitoring. Discussing all treatment pathways with an oncology team remains the best step for navigating a new diagnosis.
Further reading
Learn more about evolving clinical approaches in Cancer.
Source note: This article includes information reported by CBS News.
Live Poll
Would you trust a doctor’s recommendation to monitor early-stage cancer rather than choosing immediate surgery?
